Look For Institutional Buying In Day One Biopharmaceuticals Inc (NASDAQ: DAWN)

Day One Biopharmaceuticals Inc (DAWN) concluded trading on Thursday at a closing price of $14.72, with 4.07 million shares of worth about $59.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.22% during that period and on October 31, 2024 the price saw […]